MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

MEDX 31.58

+1.4%

Nov 5 12:44 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	3/1/2008 3:35:05 PM
	of 2240

Understanding the Evolving Role of Immunotherapy in the Treatment of Malignant Melanoma (Slides With Audio) CME Steven J. O'Day, MD Jedd D. Wolchok, MD, PhD medscape.com This is a very interesting audio/slides presentation with the main focus on responses seen in patients treated with ipilimumab. Not surprisingly the presentation has been supported financially by BMY and MEDX. I support it is a part of an offensive from the companies to make the FDA think differently about endpoints for these types of trials. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next